drugset

drugset / Trial / NCT01451164

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

NCT01451164 ↗

Phase 2/3 Completed 459 enrolled Otsuka Pharmaceutical Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate the efficacy and safety of OPC-34712 in comparison with placebo in patients with schizophrenia.

Timeline

Start: 2011-10
Primary completion: 2015-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brexpiprazole	Small molecule	—	Oral

Indications